Low-Density Cholesterol Subfractions: Not all LDL-C Particles are Created Equal
...-density lipoprotein cholesterol (LDL-C); good and bad cholesterol. In the past couple of decades, the National Cholesterol Education Program (NCEP) recommendations have evolved from the total cholesterol test to a fasting lipoprotein profilecomprised of total cholesterol, HDL-C, LDL-C and triglycerides.......EPShypothesis that hormones may be good early, but bad late," Dr.Harman said. This latest study follows an April article in the Journal of theAmerican Medical Association, which found a 24 percent reduction inrisk for coronary heart disease in women starting hormone therapyless than ten years after meno......questionnaire that evaluated intensity ofpain on a bad day on a scale of 0-10, with 10 being the greatest... being extreme pain, howintense was your pain on a bad day?" The mean scores for intensityof pain at baseline were 6.3 for the Proellex groups and 6.1 fort......ely 28 million Americans,primarily women. Unlike a bad headache, migraines are characterizedby attacks of intense, usually one-sided, throbbing head pain thatcan last from four to 72 hours. The pain associated with migraineis frequently accompanied by other associated symptoms, includingnausea, vomiting ......ment/resolution of the clinical signs ofinfection, bad odour reduction, white blood cells count andduration of hospitalization. The study, led by investigators E. Ricci, S. Astolfi and R.Cassino of the operative unit of vulnology at the San Luca Clinicin Turin, Italy, concluded that the Microcyn Technol......and very low-densitylipoproteins, or VLDL-C, being bad forms directly involved in heartdisease. Collectively, LDL-C, VLDL-C, and other bad forms ofcholesterol are referred to as "non-HDL-C." The lowering ofnon-HDL-C is a key component in t...Cholesterol Drug Fails to Slow Progression of Coronary Disease, Cleveland Clinic Study Reports
...kedlyincreased good cholesterol levels and lowered bad cholesterol inpatients. Unfortunately this drug also substantially raised bloodpressure and failed to slow the buildup of plaque," Dr. Nissensaid. "It is yet to be determined of this failure represents aproblem unique to torcetrapib or predicts a lac...